CDK ASSOCIATES, L.L.C., Ten Percent Owner at Strongbridge Biopharma, holds 8.06M shares in Strongbridge Biopharma (Ticker: SBBP), holds 1.58M shares in Molecular Templates (Ticker: MTEM). Most recently, CDK ASSOCIATES, L.L.C. Bought ― shares of Strongbridge Biopharma on Sep 21, 2020 for an estimated value of $3.33M.
What is the percentage of profitable transactions made by CDK ASSOCIATES, L.L.C.?
The percentage of profitable transactions made by CDK ASSOCIATES, L.L.C. is 22%.
What is the average return per transaction made by CDK ASSOCIATES, L.L.C.?
The average return per transaction made by CDK ASSOCIATES, L.L.C. is -2.80%.
What stocks does CDK ASSOCIATES, L.L.C. hold?
CDK ASSOCIATES, L.L.C. holds: SBBP, MTEM stocks.
What was CDK ASSOCIATES, L.L.C.’s latest transaction?
CDK ASSOCIATES, L.L.C. latest transaction was an Informative Buy of $3.33M.
What was CDK ASSOCIATES, L.L.C.'s most profitable transaction?
CDK ASSOCIATES, L.L.C.’s most profitable transaction was an Informative Buy of MTEM stock on December 28, 2018. The return on the trade was 287.50%.
What is CDK ASSOCIATES, L.L.C.'s role in Strongbridge Biopharma?
CDK ASSOCIATES, L.L.C.'s role in Strongbridge Biopharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.